Home›Companies›Biotech & Pharma›Corvia Medical

Corvia Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 25, 2025·Suggest an edit

About Corvia Medical

Corvia Medical is a private company based in Tewksbury, Massachusetts. It has reported $59,863,036 raised in four offerings on Form D since March 2013. Its chief executive is George Fazio.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 12, 2025Jun 25, 2025$8,860,552of $11.0M target10$886KEquityRule 506(b)Form D ↗
Jan 15, 2021Jan 25, 2021$6,265,647of $13.1M target25$250KEquityRule 506(b)Form D ↗
Jun 16, 2014Jul 1, 2014amended Sep 22, 2015$34,000,001fully sold9$3.7MEquityRule 506(b)Form D/A ↗1 earlier filing
Mar 1, 2013Mar 15, 2013$10,736,836fully sold10$1.0MEquity06Form D ↗
Total, four offerings$59,863,036

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Corvia Medical's Form D filed Jun 25, 2025.

KG
Kevin Gillis
Director
GB
Gerald Brunk
Director
GF
George Fazio
Chief Executive Officer and director
DC
Dan Curtis
Executive officer
IY
Irit Yaniv
Director

Earlier filings also listed Uri Geiger (director, last listed Jan 2021), Mark Levin (director, last listed Jan 2021), Hemant Taneja (director, last listed Jan 2021) and Gerry Brunk (director, last listed Jan 2021).

Sources

  1. SECCorvia Medical, Inc. Form D, filed Jul 1, 2014
  2. SECCorvia Medical, Inc. filing history